Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Joni Cobb and Pipeline took ‘a leap of faith’ that’s paying off
In 2006, Joni Cobb was busy coaxing Kansas business executives to apply for a program honing their leadership skills. Then a state-subsidized program, Pipeline would cultivate promising entrepreneurs that would tangentially grow the Sunflower State’s economy with their firms. Extolled as rigorous, the Pipeline sales pitch hit snags with its intensiveness and novelty. Skeptical entrepreneurs…
The Pipeline fellowship’s journey to the Emerald Isle in photos
In an educational adventure focused on finance and global business strategy, the Pipeline entrepreneurial fellowship program ventured across the pond for a week of relationship building. I tagged along not only to observe the experience — expect more on that front soon — but to capture some moments with my camera. This smattering of photos, which…
Kansas City startups flex pitch skills in national Kauffman contest
Four Kansas City area startups — and one Lawrence, Kan. firm — have qualified to the top 40 of Ewing Marion Kauffman Foundation’s 1 in a Million pitch competition. The competition offers those who have presented at 1 Million Cups in the last year a chance to snag a $25,000 prize. Hundreds of applicants — who…
Big Bang leverages smart city success, LaunchKC momentum
Editor’s note: This content is sponsored by LaunchKC but independently produced by Startland News. As Kansas City becomes a hotbed for smart city tech, one local startup is providing a spine for streamlined communication among the devices cities will leverage. Kansas City-based Big Bang’s Internet of Things software aims to work as the “central nervous…